Luoxin Pharmaceuticals Group Stock Co., Ltd. (002793.SZ)

CNY 3.57

(-2.99%)

Market Cap (In CNY)

3.78 Billion

Revenue (In CNY)

2.34 Billion

Net Income (In CNY)

-661.13 Million

Avg. Volume

18.82 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.22-5.8
PE
-5.49
EPS
-0.65
Beta Value
0.504
ISIN
CNE1000026S7
CUSIP
-
CIK
-
Shares
1061562138.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Mr. Zhenteng Liu
Employee Count
-
Website
https://www.luoxin.cn
Ipo Date
2016-04-15
Details
Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers medical treatment and health services. The company was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and changed its name to Luoxin Pharmaceuticals Group Stock Co., Ltd. in April 2020. Luoxin Pharmaceuticals Group Stock Co., Ltd. is based in Linyi, China.